Cargando…

Obesity-Related Metabolic Syndrome: Mechanisms of Sympathetic Overactivity

The prevalence of the metabolic syndrome has increased worldwide over the past few years. Sympathetic nervous system overactivity is a key mechanism leading to hypertension in patients with the metabolic syndrome. Sympathetic activation can be triggered by reflex mechanisms as arterial baroreceptor...

Descripción completa

Detalles Bibliográficos
Autores principales:	Canale, Maria Paola, Manca di Villahermosa, Simone, Martino, Giuliana, Rovella, Valentina, Noce, Annalisa, De Lorenzo, Antonino, Di Daniele, Nicola
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2013
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3833340/ https://www.ncbi.nlm.nih.gov/pubmed/24288531 http://dx.doi.org/10.1155/2013/865965

Ejemplares similares

MOSH Syndrome (Male Obesity Secondary Hypogonadism): Clinical Assessment and Possible Therapeutic Approaches
por: De Lorenzo, Antonino, et al.
Publicado: (2018)

Plasma and erythrocyte membrane phospholipids and fatty acids in Italian general population and hemodialysis patients
por: Dessì, Mariarita, et al.
Publicado: (2014)

Atherosclerosis, Dyslipidemia, and Inflammation: The Significant Role of Polyunsaturated Fatty Acids
por: Dessì, Mariarita, et al.
Publicado: (2013)

Preoperative Embolization Reduces the Risk of Cathecolamines Release at the Time of Surgical Excision of Large Pelvic Extra-Adrenal Sympathetic Paraganglioma
por: Di Daniele, Nicola, et al.
Publicado: (2012)

Impact of Mediterranean diet on metabolic syndrome, cancer and longevity
por: Di Daniele, Nicola, et al.
Publicado: (2016)

Increased Sympathetic Renal Innervation in Hemodialysis Patients Is the Anatomical Substrate of Sympathetic Hyperactivity in End‐Stage Renal Disease
por: Mauriello, Alessandro, et al.
Publicado: (2015)

Potential Cardiovascular and Metabolic Beneficial Effects of ω-3 PUFA in Male Obesity Secondary Hypogonadism Syndrome
por: Noce, Annalisa, et al.
Publicado: (2020)

Coronary artery calcifications predict long term cardiovascular events in non diabetic Caucasian hemodialysis patients
por: Noce, Annalisa, et al.
Publicado: (2015)

Association of Gut Hormones and Microbiota with Vascular Dysfunction in Obesity
por: Rovella, Valentina, et al.
Publicado: (2021)

Fenoldopam Mesylate: A Narrative Review of Its Use in Acute Kidney Injury
por: Noce, Annalisa, et al.
Publicado: (2019)

Sympathetic Overactivity in Chronic Kidney Disease: Consequences and Mechanisms
por: Kaur, Jasdeep, et al.
Publicado: (2017)

Can Serum Cystatin C predict long-term survival in cardiac surgery patients?
por: Rovella, Valentina, et al.
Publicado: (2018)

Gut Microbioma Population: An Indicator Really Sensible to Any Change in Age, Diet, Metabolic Syndrome, and Life-Style
por: Annalisa, Noce, et al.
Publicado: (2014)

Impact of Gut Microbiota Composition on Onset and Progression of Chronic Non-Communicable Diseases
por: Noce, Annalisa, et al.
Publicado: (2019)

Sympathetic Motor Neuron Dysfunction is a Missing Link in Age-Associated Sympathetic Overactivity
por: de la Cruz, Lizbeth, et al.
Publicado: (2023)

Brown Tumour in a Patient with Secondary Hyperparathyroidism Resistant to Medical Therapy: Case Report on Successful Treatment after Subtotal Parathyroidectomy
por: Di Daniele, Nicola, et al.
Publicado: (2009)

The risk of carotid plaque instability in patients with metabolic syndrome is higher in women with hypertriglyceridemia
por: Servadei, Francesca, et al.
Publicado: (2021)

Stroke‐induced chronic systolic dysfunction driven by sympathetic overactivity
por: Bieber, Michael, et al.
Publicado: (2017)

Female Sex as a Thromboembolic Risk Factor in the Era of Nonvitamin K Antagonist Oral Anticoagulants
por: Gallù, Mariacarla, et al.
Publicado: (2020)

The Onco-Nephrology Field: The Role of Personalized Chemotherapy to Prevent Kidney Damage
por: Noce, Annalisa, et al.
Publicado: (2023)

Natural Bioactive Compounds Useful in Clinical Management of Metabolic Syndrome
por: Noce, Annalisa, et al.
Publicado: (2021)

Aging is associated with glial senescence in the brainstem - implications for age-related sympathetic overactivity
por: Balasubramanian, Priya, et al.
Publicado: (2021)

Erythrocyte glutathione transferase in kidney transplantation: a probe for kidney detoxification efficiency
por: Bocedi, Alessio, et al.
Publicado: (2018)

Gut Dysbiosis and Western Diet in the Pathogenesis of Essential Arterial Hypertension: A Narrative Review
por: Canale, Maria Paola, et al.
Publicado: (2021)

Nonselective Blocking of the Sympathetic Nervous System Decreases Detrusor Overactivity in Spontaneously Hypertensive Rats
por: Kim, Khae-Hawn, et al.
Publicado: (2012)

Vagal Withdrawal and Sympathetic Overactivity Contribute to the Genesis of Early-Onset Pregnancy-Induced Hypertension
por: Pal, G. K., et al.
Publicado: (2011)

Nutritional Approaches for the Management of Metabolic Acidosis in Chronic Kidney Disease
por: Noce, Annalisa, et al.
Publicado: (2021)

Biomarkers of Glyco-Metabolic Control in Hemodialysis Patients: Glycated Hemoglobin vs. Glycated Albumin
por: Martino, Francesca Gabriela, et al.
Publicado: (2021)

Obesity: sex and sympathetics
por: Shi, Zhigang, et al.
Publicado: (2020)

New Insights on the Maternal Diet Induced-Hypertension: Potential Role of the Phenotypic Plasticity and Sympathetic-Respiratory Overactivity
por: Costa-Silva, João H., et al.
Publicado: (2015)

Relevance of Sympathetic Nervous System Activation in Obesity and Metabolic Syndrome
por: Thorp, Alicia A., et al.
Publicado: (2015)

Chronic Kidney Disease as a Systemic Inflammatory Syndrome: Update on Mechanisms Involved and Potential Treatment
por: Tinti, Francesca, et al.
Publicado: (2021)

Lp-PLA(2), a new biomarker of vascular disorders in metabolic diseases
por: De Stefano, Alessandro, et al.
Publicado: (2019)

Neurotoxic Effect of Doxorubicin Treatment on Cardiac Sympathetic Neurons
por: Moro, Nicola, et al.
Publicado: (2022)

Sympathetic overactivity prevails over the vascular amplifier phenomena in a chronic kidney disease rat model of hypertension
por: Ameer, Omar Z., et al.
Publicado: (2014)

Sympathetic Overactivity Based on Heart-Rate Variability in Patients with Obstructive Sleep Apnea and Cerebral Small-Vessel Disease
por: Moon, Jangsup, et al.
Publicado: (2018)

Vegan Diet Health Benefits in Metabolic Syndrome
por: Marrone, Giulia, et al.
Publicado: (2021)

Effect of Hydrolysable Tannins and Anthocyanins on Recurrent Urinary Tract Infections in Nephropathic Patients: Preliminary Data
por: Noce, Annalisa, et al.
Publicado: (2021)

Usefulness of Extra Virgin Olive Oil Minor Polar Compounds in the Management of Chronic Kidney Disease Patients
por: Noce, Annalisa, et al.
Publicado: (2021)

Is low-protein diet a possible risk factor of malnutrition in chronic kidney disease patients?
por: Noce, A, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_5pcnil2161oo03tn9uf39uj6po